Skip to main content
. 2022 Oct 31;54(1):3069–3078. doi: 10.1080/07853890.2022.2138530

Figure 2.

Figure 2.

RNA-seq shows ncRNA may be dysregulated in CSF from ALS patients. (A) Workflow of the experiment from sample to sequencing data. (B) Summary of the number of aligned reads that were annotated and the ncRNA species they aligned to. (C) MA plots of ncRNA dysregulation in slow- (ALS-SP) and fast-progression (ALS-FP) ALS patients compared to healthy controls, and ALS-FP compared to ALS-SP. Dots in red were significantly dysregulated compared to healthy control (horizontal dotted line representing p < 0.05).